PillPack, acquired by Amazon last year, was informed last week that Surescripts was planning to cut off its access to patient drug data, which comes from a third-party entity, ReMyHealth. According to CNBC, this could seriously harm Pillpack’s business.
PillPack’s service relies on this data to maintain an accurate list of patient medications, so it can help them keep up with refills and uncover duplicate subscriptions.
Although PillPack doesn’t contract directly with Surescripts for patient data, it uses ReMyHealth, which compiles raw data from Surescripts, cleans it up and offers it to clients.
Amazon is considering legal action against Surescripts to prevent the e-prescribing company from ending its access to the data from ReMyHealth.
More articles on pharmacy:
Oklahoma opioid trial wraps: 10 takeaways
Drugmaker tried to shred records before FDA inspection, agency claims
New Jersey physician, pharmacy workers charged in $10M kickback scheme
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
